PharmAust secures broad patent coverage for non-cancer applications
170517_PharmAust secures broad patent coverage for non-cancer applications
News & Announcements from PharmAust in 2017
Investor Presentation (May)
170522_Investor Presentation (May)
PharmAust secures core China patent
170505_PharmAust secures core China patent
Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017
170413_Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017
Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust
170308_Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust
PharmAust raises a further $534K
170303_PHARMAUST RAISES A FURTHER $534k
Dr Richard Hopkins Appointed as CEO of PharmAust
170301_Dr Richard Hopkins Appointed as CEO of PharmAust
Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016
170131_Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016
PharmAust receives $406K R&D rebate from ATO
170130_PHARMAUST RECEIVES $406K R&D REBATE FROM ATO
Appendix 4D Half-Year Report for the period ended 31 December 2016
170228_Appendix 4D Half-Year Report for the period ended 31 December 2016